Cargando…

Real-World Use and Outcomes of Olaparib: a Population-Based Cohort Study

BACKGROUND: Although olaparib, the first poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor approved, has been used in routine clinical practice for over three years, little has been published on its uptake, utilization patterns, and clinical outcomes. OBJECTIVE: To examine real-w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eriksson, Irene, Wettermark, Björn, Bergfeldt, Kjell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297279/ https://www.ncbi.nlm.nih.gov/pubmed/30446872 http://dx.doi.org/10.1007/s11523-018-0604-z

Ejemplares similares

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study
por: Eriksson, Irene, et al.
Publicado: (2017)

Antibiotic use and bacterial complications following upper respiratory tract infections: a population-based study
por: Cars, Thomas, et al.
Publicado: (2017)

Real‐world clinical outcomes of olaparib therapy in Chinese patients with advanced serous ovarian cancer treated in Macau
por: Cao, Yabing, et al.
Publicado: (2019)

Olaparib outcomes in metastatic castration-resistant prostate cancer: First real-world experience in safety and efficacy from the Chinese mainland
por: Pan, Jian, et al.
Publicado: (2022)

Olaparib treatment in older patients with ovarian cancer: need for ‘real-world’ data beyond clinical trials
por: Liposits, Gabor, et al.
Publicado: (2020)

Olaparib in the therapy of advanced ovarian cancer: first real world experiences in safety and efficacy from China
por: Ni, Jing, et al.
Publicado: (2019)

Forecasting drug utilization and expenditure: ten years of experience in Stockholm
por: Linnér, Love, et al.
Publicado: (2020)

A real or apparent decrease in glomerular filtration rate in patients using olaparib?
por: Bruin, M. A. C., et al.
Publicado: (2020)

A Real-World Disproportionality Analysis of Olaparib: Data Mining of the Public Version of FDA Adverse Event Reporting System
por: Shu, Yamin, et al.
Publicado: (2022)

Initiation of antihypertensive drugs to patients with confirmed COVID‐19—A population‐based cohort study in Sweden
por: Mousa, Salar Issa, et al.
Publicado: (2022)

Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia
por: Geelen, Inge G.P., et al.
Publicado: (2017)

Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study
por: De Giorgi, Riccardo, et al.
Publicado: (2023)

Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
por: Bellier, Charlotte, et al.
Publicado: (2023)

Protective effects of statins on COVID-19 risk, severity and fatal outcome: a nationwide Swedish cohort study
por: Santosa, Ailiana, et al.
Publicado: (2022)

Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System
por: Eriksson, Irene, et al.
Publicado: (2018)

Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
por: Ställberg, Björn, et al.
Publicado: (2018)

Gender differences among Swedish COPD patients: results from the ARCTIC, a real-world retrospective cohort study
por: Lisspers, Karin, et al.
Publicado: (2019)

Treatment Patterns, Socioeconomic Status and Clinical Burden in Mild COPD: A Swedish Real-World, Retrospective Cohort Study, the ARCTIC Study
por: Larsson, Kjell, et al.
Publicado: (2022)

Olaparib in the management of ovarian cancer
por: Bixel, Kristin, et al.
Publicado: (2015)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Olaparib: Transcending mutational barriers
por: Chandna, Abhishek
Publicado: (2019)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
por: Paik, E Sun, et al.
Publicado: (2019)

Real-World Management and Clinical Outcomes of Stroke Survivors With Atrial Fibrillation: A Population-Based Cohort in Spain
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2021)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations
por: Eriksson, Irene, et al.
Publicado: (2018)

Drug–disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension – a population-based registry study
por: Schmidt-Mende, Katharina, et al.
Publicado: (2020)

A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer
por: Geenen, Jill J. J., et al.
Publicado: (2021)

Understanding real‐world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population‐based cohort study
por: Jimenez‐Zepeda, Victor H., et al.
Publicado: (2022)

Visual Outcomes of Anti-VEGF Treatment on Neovascular Age-Related Macular Degeneration: A Real-World Population-Based Cohort Study
por: Korva-Gurung, Ida, et al.
Publicado: (2023)

Real-world visual outcomes of cataract surgery based on population-based studies: a systematic review
por: Han, Xiaotong, et al.
Publicado: (2023)

The combination of olaparib and camptothecin for effective radiosensitization
por: Miura, Katsutoshi, et al.
Publicado: (2012)

Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol
por: Mansouri, Anita, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient Populations
por: Pilla Reddy, Venkatesh, et al.
Publicado: (2018)

PET Imaging of PARP Expression Using (18)F-Olaparib
por: Wilson, Thomas C., et al.
Publicado: (2019)

Real-World Analyses of the Safety Outcome among a General Population Treated with Statins: An Asian Population-Based Study
por: Lin, Jia-Ling, et al.
Publicado: (2022)

A real‐world, population‐based study of patterns of referral, treatment, and outcomes for advanced pancreatic cancer
por: Abdel‐Rahman, Omar, et al.
Publicado: (2018)

Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD – Real-World Data from a Primary Care Setting
por: Ellingsen, Jens, et al.
Publicado: (2020)

Impact of Kawasaki disease on juvenile idiopathic arthritis in real-world patients: A population-based cohort study
por: Liao, Li-Chin, et al.
Publicado: (2022)

Real-world data of HER2-low metastatic breast cancer: A population based cohort study
por: Holthuis, Emily I., et al.
Publicado: (2022)

Clinic continuity of care, clinical outcomes and direct costs for COPD in Sweden: a population based cohort study
por: Sveréus, Sofia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_at7kus5m42cahfjm3vvnvmahp0